HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

11-hydroxyaclacinomycin X

isolated from Streptomyces galilaeus; structure in first source

Also Known As:

3'''-amino-11-hydroxyaclacinomycin Y; ID-6105

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cho, Byung Suk: 1 article (10/2008)
2.	Choi, Kyu Seok: 1 article (10/2008)
3.	Chung, Youn Bok: 1 article (10/2008)
4.	Kim, Tae-Yong: 1 article (10/2008)
5.	Lee, Chong-Kil: 1 article (10/2008)
6.	Lee, Hong-Sub: 1 article (10/2008)
7.	Park, Sang-Ae: 1 article (10/2008)
8.	Ryu, Jung-Su: 1 article (10/2008)
9.	Shin, Dae Hwan: 1 article (10/2008)
10.	Song, Sukgil: 1 article (10/2008)

Related Diseases

1.	Ovarian Neoplasms (Ovarian Cancer) 10/01/2008 - "Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells." 10/01/2008 - "We investigated the anticancer activity of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, on weakly doxorubicin (Dox)-resistant SK-OV-3 ovarian cancer cells, and elucidated the relationship between its anticancer activity and accumulation in cells compared with those of Dox. "
2.	Neoplasms (Cancer) 10/01/2008 - "These results show that accumulation of ID-6105 within tumor cells may be important for the inhibitory effects of this drug in cancer cells. "

Related Drugs and Biologics

1.	Anthracyclines
2.	Doxorubicin (Adriamycin)